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Abstract
Background: Periodontal disease is thought to arise from the interaction of various factors, including the susceptibility
of the host, the presence of pathogenic organisms, and the absence of beneficial species. The genetic factors may play
a significant role in the risk of periodontal diseases. Cytokines initiate, mediate and control immune and inflammatory
responses. The aim of this study is to compare genotypes and soluble protein of pro and anti-inflammatory cytokines
(IL-1a, IL-1b, IL-6, IFN-g, IL-10, TNF-a and IL-4) in subjects with or free of chronic periodontitis.
Methods: A total of 1,290 Chinese subjects were recruited to this clinical trial: 850 periodontally healthy controls and
440 periodontal patients. All subjects were free of systemic diseases. Oral examinations were performed, and the
following parameters were recorded for each subject: supragingival/subgingival calculus, gingival recession, bleeding
on probing (BOP), probing depth (PD), clinical attachment loss (CAL), gingival recession and tooth mobility. The
peripheral blood samples were collected for genetic and enzyme linked immunosorbent assay (ELISA) analysis.
Restriction enzymes were used for digestion of amplified fragments of IL-1a, IL-1b, IL-6, IFN-g, IL-10, TNF-a and IL-4.
Results: The protein expressions of patient and control samples for IL-1a, IL-1b, IL-6, TNF-a, IFN-g, IL-10, and IL-4
measured by ELISA confirmed a statistically significant difference (p < 0.001). The digestion of fragments of various
genes showed that the pro-inflammatory cytokines IL-1a and TNF-a, and the anti-inflammatory cytokines IL-4 and
IL-10 demonstrated a correlation with chronic inflammation in patients (X2: p < 0.001). The remaining genes
investigated in patients and healthy subjects (IL-1b, IL-6, IFN-g and IL-10) did not show any significant difference.
Conclusions: The cytokine gene polymorphisms may be used as a marker for periodontitis susceptibility, clinical
behaviour and severity. This detection offers early diagnosis and induction of prophylaxis to other family members
against disease progression.
Background
Periodontal disease is thought to arise from the interac-
tion of various factors, including the susceptibility of the
host, the presence of pathogenic organisms and the
absence of beneficial species [1]. Although bacteria
cause plaque-induced inflammatory periodontal diseases,
progression and clinical characteristics of these diseases
are influenced by both acquired and genetic factors that
can modify susceptibility to infection [2] Reports have
indicated that genetic factors may play a significant role
in the risk of periodontal diseases [3,4].
Cytokines are soluble proteins which are secreted by
cells to act as a messenger that transmits signals to other
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cells. They initiate, mediate and control immune and
inflammatory responses; they also regulate growth and
differentiation of cells [4]. Gingival epithelial cells pro-
duce a broad range of cytokines, among which, interleu-
kin-1a (IL-1a), interleukin-1b (IL-1b), tumour necrosis
factor-a (TNF-a), interleukin-6 (IL-6) and interferon-g
(IFN-g) are the pro-inflammatory cytokines whereas
interleukin-4 (IL-4) and interleukin-10 (IL-10) are the
anti-inflammatory cytokines [5-7].
IL-1 consists of at least two separate gene products, IL-
1a and IL-1b, which have common biological activities
but limited homology at the nucleotide and peptide levels
[8]. The gene encoding IL-1 is assigned to chromosome
2q13–21 [9]. The carriage of certain alleles of IL-1a and
IL-1b is associated with the incidence and the severity of
periodontal disease, in particular chronic periodontitis
(CP), because these carriers produce more IL-1 in
response to plaque than genotype negative individuals
[2,10,11]. The presence of a single base-pair C-T tranposi-
tional polymorphism upstream of the IL-1a gene at posi-
tion -889 affects the production of the IL-1a protein. The
IL-1 a -889 T allele was associated with an almost four-
fold increase in IL-1 a levels in gingival crevicular fluid
[12]. A weak positive association was found concerning
IL-1b T(-511)C and chronic periodontal disease [13]. In
other studies, no association was found for IL-1a C(-889)
T and -1b T(-511)C with aggressive periodontitis [13,14].
TNF-a is located in 6p21.3 of chromosome 6 within the
major histocompatibility complex [15]. Eight single nucleo-
tide polymorphisms (SNPs) in the promoter region of this
gene have been studied at positions -1031T/C, -863C/A,
-857C/T, -575G/A, -376G/A, -308G/A, -244G/A, and
-238G/A [16-19]. Many researchers investigated the possi-
ble link between the -308 polymorphism in the TNF-a
gene and periodontitis because a G to A polymorphism at
the -308 position of the TNF-a promoter region was sug-
gested to influence TNF-a production and monocytes of
patients with periodontitis [20,21]. Higher allele 2 fre-
quency was observed in patients with chronic periodontitis
than in healthy individuals [22]. Aggressive periodontitis
was not linked to this locus [23-25]. The remaining promo-
ter polymorphisms were not associated with periodontitis,
apart from one study that found an association between
the -1031, -863, -857 SNPs and chronic periodontitis sever-
ity in the Japanese population [23,26,27].
The IL-6 gene is assigned to chromosome 7p21. Various
SNPs in the promoter region of this gene have been stu-
died at positions -174G/C, -190C/T, -572C/G, -597G/A,
-1363G/T, -1480C/G and -6106A/T [28,29]. In periodonti-
tis, the G–C SNP at the -174 position correlated with
chronic periodontitis susceptibility in Brazilians and Cau-
casians, but not the Japanese [30,31]. Periodontitis patients
carrying one or two copies of the rare allele in the IL-6
-174 polymorphism displayed significantly higher serum
IL-6 and C-reactive protein concentrations [32]. Carriers
of the rare allele at this position was associated with less
reduction in probing depths among chronic periodontitis
patients after delivery of standard non-surgical periodontal
therapy [33]. On the contrary, another study found that
the -174 R-allele carrier individuals have decreased plasma
levels of IL-6 and lower IL-6 gene transcriptional activity
compared with N/N individuals, suggesting that low IL-6
response may hamper an individual’s defense against peri-
odontal pathogens [34]. In a meta-analysis of cytokine
gene polymorphisms of 53 studies, the IL-6 -174 poly-
morphism did not exhibit any association with chronic
periodontitis (CP) [13].
The mRNA expression and/or concentration of IFN-g in
gingival crevicular fluid, gingival tissues, and serum were
able to affect gingivitis, probing depths and alveolar bone
loss [35]. Very few studies have investigated the connec-
tion of polymorphism of IFN-g with periodontitis to date.
Polymorphism in gene IFN-g was found to be functionally
relevant and causes differences in the immunoregulatory
activity of its cytokine molecules. The T allele of the IFN-g
874 T/A is found in high producers of IFN-g [36]. No
association was found in the only existing study dealing
with the IFN- g polymorphism 874T/A and CP [37].
The gene for IL-4 is localized in chromosome 5q31.1
[38]. The presence of IL-4-producing cells and the percen-
tage of IL-4-expressing cells were significantly higher in
established and severe periodontitis lesions than in gingivi-
tis tissues. IL-4 levels in the serum of patients were higher
in chronic periodontitis but these levels did not correlate
with the degree of bone loss or pocket formation [39].
Mout et al. identified promoter SNP at position -590 and
a 70-bp variable numbers of tandem repeat (VNTR) poly-
morphism at intron 2 [40]. However, many reports have
failed to establish a connection between these loci and
periodontal disease susceptibility and severity [41,42].
The gene encoding IL-10 was mapped to chromosome
1q31–32 [43]. The -1082 G/A locus was not associated
with chronic periodontitis susceptibility in most Caucasian
populations except in one Swedish study, but was linked
to CP severity [44]. The -1082 single nucleotide poly-
morphism was associated with high in vitro IL-10 produc-
tion [45]. There was a complete absence of the N-allele
carriage at position -1082 among the Japanese in contrast
to Caucasians where the -1082 N-allele is the most occur-
ring variant [45,46].
The aim of this study is to compare genotypes and solu-
ble protein (serum) of pro and anti-inflammatory cyto-
kines in subjects with or free of chroinic periodontitis.
Methods
Selection of subjects and clinical examination
From September 2004 to March 2007, a total of 1,290
subjects were recruited to this clinical trial: 850
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periodontally healthy subjects and 440 periodontitis
patients. Healthy subjects were selected from colleges
and the community setting to be in the control group.
They were invited for oral clinical examinations at West
China Hospital of Stomatology, Sichuan University,
PRC. Among the 850 healthy controls, 306 were female
and 544 were male, with an average age of 42.9 years.
440 periodontal patients (180 females and 260 males,
aged 28 to 65 years) with moderate to severe chronic
periodontitis were recruited from West China Hospital
of Stomatology, Sichuan University, PRC. The data of
the recruited subjects are presented in Table 1.
The sample size of this study was determined based on
the reports of Machin and Lemeshow. In the report, the
sample size was calculated based on 0.05 level of signifi-
cance for two arms to achieve 90% power [47,48]. The
study protocols were approved by the Ethics Committee,
West China Hospital of Stomatology, Sichuan University.
Informed consent was obtained from all subjects.
The diagnosis of CP was made following the criteria
defined by the American Academy of Periodontology in
1999 [49]. The periodontal disease classification system
forms the basis for the criteria of diagnosis of periodontitis
[2,49,50].
All subjects were free of oral soft tissue abnormalities
or severe dental caries. An intra-oral examination of
periodontal conditions including supragingival/subgingi-
val calculus, gingival recession, bleeding on probing
(BOP), probing depth (PD), clinical attachment loss
(CAL), gingival recession and tooth mobility was per-
formed. The diagnostic criteria for periodontitis were
referred to the 1999 International Classification of the
Periodontal Disease and Conditions [49]. Subjects who
were examined and determined to be free of periodontal
disease, gingival recession, CAL and probing depth of
greater than 3 mm were regarded as periodontally
healthy. If subjects presented with probing depth of
greater than 5 mm, CAL greater than 4 mm, some
degree of gingival recession and tooth mobility, they
were regarded to be severe chronic periodontitis patients
[13,23,31].
Preparation of control and patient blood samples
Peripheral blood samples were collected by direct veni-
puncture from the arm vein of each subject: 20 ml in
lithium heparin tubes and 10 ml in clot blood tubes (BD
Vacutainer, NJ USA). The samples were certrifuged for
10 min at 1,500 rpm, and serum and plasma was then
collected for enzyme linked immunosorbent assay
(ELISA) analysis. The remaining cellular components
were transferred to a 50 ml centrifuge tube and an addi-
tional 45 ml red blood cell lysis buffer was added. The
tube was inverted several times and then centrifuged for
10 min at 1,500 rpm. The supernatants were discarded,
and the remaining components were washed with 0.9%
PBS used for DNA extraction.
Extraction of DNA from samples and polymerase chain
reaction (PCR) to amplify the polymorphic site
Genomic DNA was extracted from blood samples fol-
lowing the blood protocols from the QIAamp DNA
Blood Mini Kit (QIAGEN, MD, USA). The concentra-
tion of DNA was estimated by measurements of OD260
by a spectrophotometer (U1800, Hitachi, Japan).
Extracted DNA was labeled and stored at -80°C until
use.
A PCR kit (Promega Corporation, U.S.A), consisting of
nuclease-free water and PCR Master Mix was used
according to the manufacturer’s instructions. The PCR
Master Mix includes 50 units/ml Taq DNA Polymerase
supplied in a proprietary reaction buffer (pH 8.5), 400 μM
of dATP, dGTP, dCTP, and dTTP, in addition to 3 mM of
MgCl2. All procedures were carried out in a sterile and
stable environment to prevent external contamination.
PCR was undertaken in a thermal cycler (MJ, U.S.A.)
with a mixture containing 20 units of nuclease-free water,
25 units of PCR Master Mix, 0.5 units of each designed
cytokine genes primer (Invitrogen, USA) (Table 2 & 3).
All primers were designed using the Roche UPL Primer
Design Program, and 3 units of the extracted DNA sample
were mixed to undergo thermal cycling. The thermal
cycler was applied for PCR amplification of the DNA sam-
ples according to conditions set out in Table 2[13,23,31].
All products from thermal cycling were labeled accord-
ingly and stored at -80°C until use. In this study, b-actin
was used (Table 2) with the forward primer 5’-
CCTCTATGCCAACACAGTGC-3’and reverse primer 5’-
ATACTCCTGCTTGCTGATCC -3’. b-actin is considered
to be a constitutive housekeeping gene for PCR, having
been used to compare changes in specific gene expressions
[51].








Age (years) 42.9 ± 9.7 49.3 ± 13.6
Age range (years) 26 - 60 28 - 65
Male / female 544 / 306 260 / 180
PD (mm) 2.7 ± 1.2 6.1 ± 2.7*
Sites% with BOP 40.3 ± 9.5 78.2 ± 19.8*
Sites% with gingival
recession
1 ± 1.2 38.9 ± 25.9*
Sites% with calculus 34.1 ± 13.6 63.0 ± 25.8
CAL (mm) 0.0 6.2 ± 2.9
PD: probing depth; BOP: bleeding on probing; CAL: clinical attachment loss.
Significant difference from the control subjects, *p < 0.05.
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Restriction digest using Fnu4H1, Aval, Nla III, Alw, Mnl I
and AvaII for IL-1a, IL-1b, IL-6, IFN-g, IL-10, and TNF-a and
IL-4 respectively
The amplified fragments generated from the PCR proce-
dure were digested: 1) the 229 bp fragment on IL-1a
was recognized by Fnu4H1 (Fermentas Life Sciences, U.
S.A.) [52], 2) the 305 bp fragment on IL-1b was recog-
nized by Aval (Fermentas Life Sciences, U.S.A.) [53], 3)
the 296 bp fragment on IL-6 was recognized by NlaIII
(Fermentas Life Sciences, U.S.A.), [54] 4) the 296 bp
fragment on IFN-g was recognized by Alw (Fermentas
Life Sciences, U.S.A.) [55], 5) the 139 bp fragment on
IL-10 was recognized by Mnl I (Fermentas Life Sciences,
U.S.A.) [56], and 6) both the 296 bp fragment on TNF-
a and 195 bp fragment on IL-4 were recognized by
AvaII (Fermentas Life Sciences, U.S.A.) [57,58].
For each digest, 10 μl of the amplified PCR product
was mixed with 2.5 to 5 units of the corresponding
restriction enzyme, 10 μl of nuclease-free water and 0.5
to 1 μl of restriction enzyme buffer. The entire mixture
was incubated for more than 4 hours at 37°C (Table 3)
[13,23,31]. All digestion reagents were kept on ice before
incubation to prevent denaturation. Every sample was
digested twice to ensure for consistency of the
amplicions.
Electrophoresis and visualization of digest product
The 10 μl of digestion product and 1 μl of Ready-Load 1
Kb DNA Ladder (Invitrogen, Spain) were loaded into 2-
4% agarose gel (Invitrogen, Spain) containing 0.5 μg/ml
of ethidium bromide [13,23,31]. The gel underwent elec-
trophoresis at 100 volts and 100 milliAmperes for 30
minutes. Afterward, the gel was visualized using a Dol-
phin-DOC ultraviolet illuminator (Wealtec, South
Africa).
Sera measured by ELISA
ELISA was performed using the serum samples, follow-
ing the manufacturer’s instructions from cytokines
ELISA Kit (Diaclone, France) [59]. The normal detection
ranges of biomarkers are detailed in Table 4. The proce-
dures were as follows: 100 μl of the standard group
solutions and serum of each subject were pipetted into a
96-well microplate. The plate was incubated for 2 to 3
hours at 350 rpm and washed with washing buffer three
times. Then the wells were dried and 200 μl of substrate
tetramethylbenizidine was added into each well for 20
min in the dark at room temperature. The plates were
read at 450 nm wavelength using Universal Microplate
Reader (Sunrise, TECAN, Austria). The levels of cyto-
kines in the samples were obtained by comparison with
the standard curve generated from standards supplied
by the manufacturer [59].
Table 2 PCR conditions for various genes
Gene Product size
(bp)
Denaturation Annealing Extension Cycles
IL-1a 229 94°C,1min 55°C, 30s 72°C, 60s 35
IL-1b 305 94°C, 5mins 56°C, 45s 72°C, 60s 35
IL-6 296 95°C, 60s 60°C, 60s 72°C, 60s 35
TNF-
a
133 94°C, 1min 61°C, 1min 72°C, 60s 35
IFN-g 366 95°C, 5mins 56°C, 30s 72°C,
5mins
30
IL-4 195 95°C, 5mins 51°C, 60s 72°C, 60s 35
IL-10 139 94°C, 30s 60°C, 45s 72°C, 60s 35
b-
actin
211 94°C, 30s 55°C, 30s 72°C, 60s 30
Table 3 The primer sequences and restriction enzymes used for detection of cytokine DNA polymorphism genes





IL-1a Forward 5’ATGGTTTTAGAAATCATCAAGCCTAGGCA-3’ -889 Fnu4H1 >12 Walker et al.
Reverse 5’AATGAAAGGAGGGGAGGATGACAGAAATGA-
3’
IL-1b Forward 5’-TGGCATTGATCTGGTTCATC-3’ -511 Aval >12 Néstor et al.
Reverse 5’-GTTTAGGAATCTTCCCACTT-3’
IL-6 Forward 5’TTGTCAAGACATGCCAAGTGCT-3’ -174 Nla III 4 Trevilatto et al.
Reverse 5’-GCCTCAGAGACATCTCCAGTCC-3’
TNF-a Forward 5’-GAAGCCCCTCCCAGTTCTAGT TC-3’ -238 AvaII 4 Sleijffers et al.
Reverse 5’-CACTCCCCATCCTCCCTGGTC-3’
IFN-g Forward 5’-GCTGTCATAATAATATTCAGAC-3’ -874 Alw 4 Inoue et al
Reverse 5’-CGAGCTTTAAAAGATAGTTCC-3’
IL-4 Forward 5’-TAAACTTGGGAGAACATGGT-3’ -590 Ava II >12 Scarel-Caminaga et
al.
Reverse 5’-TGGGGAAAGATAGAGTAATA-3’
IL-10 Forward 5’-CTCGCTGCAACCCAACTGGC-3’ -1082 Mnl I 4 Chin et al.
Reverse 5’-TCTTACCTATCCCTACTTCC-3’
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Statistical analysis
The Chi-squared test was applied to examine the differ-
ences in genotype distribution, allele frequency and car-
riage rate between healthy and patient groups. The
alleles were calculated as an odds ratio (OR) with 95%
confidence interval (95% CI) [13,23,31]. The soluble pro-
tein levels of cytokines were evaluated with an indepen-
dent t-test [59], and p < 0.05 was considered statistically
significant. Statistical analysis was performed using SPSS
18.0 for windows (SPSS Inc., U.S.A.).
Results
The clinical parameters of the healthy subjects and peri-
odontitis patients were shown in Table 1. The periodon-
titis patient group exhibited a significantly greater mean
of PD (6.1 ± 2.7 mm vs. 2.7 ± 1.2 mm), CAL (6.2 ± 2.9
mm vs 0.0) and a higher percentage of sites with BOP
(78.2 ± 19.8% vs. 40.3 ± 9.5%) and gingival recession
(38.9 ± 25.9% vs. 1 ± 1.2%) than the control group (p <
0.05). There was no significant difference found in the
age and gender ratio between the two groups.
The total blood count of the healthy control subjects
and periodontitis patients are presented in Table 4.
With regard to the clinical parameters, the results of all
subjects were within the normal range, although the
patient group exhibited a relatively higher count and
percentage of lymphocytes, and a relatively lower count
and percentage of neutrophils (p < 0.05) compared to
the periodontally healthy controls.
The protein expression of patient and control samples
for IL-1a, IL-1b, IL-6, TNF-a, IFN-g, IL-10, and IL-4
(Table 5) measured by ELISA confirmed a statistically
significant difference (p < 0.001). The digestion of frag-
ments of various genes examined under a gel documen-
tation system (Wealtec, South Africa) showed that the
pro-inflammatory cytokines IL-1a and TNF-a, and the
anti-inflammatory cytokines IL-4 and IL-10 demon-
strated an association with chronic inflammation in
patients (X2: p < 0.0001).
After digestion by Fnu4H1, IL-1a formed the DNA
products of 153 and 76 bp for homozygous C allele, and
124, 76 and 29 bp for homozygous T alleles [52]. The
detection frequency of the homozygous C allele of IL-
1a was similar in the subjects with chronic periodontitis
(62%) and control group (55%) (X2, p = 0.18), but in the
C/C genotype, the periodontitis patients presented a fre-
quency of 52%, compared to 20% in the control group.
The odds ratio for carriage of IL-1a allele (T/T + C/T
Table 4 Complete blood count (Mean ± SD) of control subjects (N = 850) and periodontitis patients (N = 440)
Parameters Control subjects Periodontitis patients Normal Range Unit
White blood cell 6.33 ( ± 1.31) 3.96 (±1.02) 4.00 - 11.00 109/L
Red blood cell 4.52 ( ± 0.13) 4.25 (±0.10) 3.8 - 6.0 1012/L
Hemoglobin 15.0 ( ± 0.50) 12.5 (±0.43) 11.5 - 16.5 g/dL
Platelet 273 ( ± 27.12) 241 (±23.31) 150 - 400 109/L
Neutrophils 4.45 ( ± 1.05) *1.68 (±0.71) 2.0 - 7.5 109/L
Lymphocytes 1.37 ( ± 0.64) *1.42 (±0.26) 1.30 - 3.5 109/L
Monocyte 0.34 ( ± 0.19) 0.18 (±0.11) 0.2 - 0.7 109/L
Eosinophil 0.12 ( ± 0.60) 0.06 (±0.02) 0.0 - 0.5 109/L
Basophil 0.05 ( ± 0.03) 0.02 (±0.01) 0.0 - 0.1 109/L
Neutrophils 70.3 ( ± 13.42) *49.9 (±11.43) 4.0 - 75.0 %
Lymphocytes 21.6 ( ± 9.06) *42.3 (±10.69) 20 - 45 %
Monocyte 5.4 ( ± 3.02) 5.4 (±2.89) 4.7 - 12.2 %
Eosinophil 1.9 ( ± 0.34) 1.8 (± 0.52) 0.7 - 7.0 %
Basophil 0.8 ( ± 0.12) 0.6 (± 0.24) 0.1 - 1.2 %
Significant difference from the control, * p < 0.05
Table 5 Protein expression (Mean ± SD) of various cytokines in patient and control groups as measured by ELISA
Cytokines Control subjects (N = 850) Periodontitis patients (N = 440) p value Detection Range pg/ml
IL-1a 24.08 ( ± 4.62) 59.73 ( ± 11.36) 0.0008 31.25 - 1000
IL-1b 19.57 ( ± 3.75) 78.07 ( ± 17.09) 0.0004 15.6 - 500
IL-6 27.35 ( ± 2.87) 92.94 ( ± 17.44) 0.0005 2 - 200
TNF-a 26.90 ( ± 4.55) 67.61 ( ± 14.60) 0.0002 8 - 800
IFN-g 52.77 ( ± 8.12) 94.71 ( ± 9.90) 0.0003 5 - 400
IL-4 1.16 ( ± 0.20) 4.62 ( ± 0.58) 0.0003 0.7 - 35
IL-10 22.70 ( ± 3.41) 46.89 ( ± 5.85) 0.0012 5 - 400
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genotypes combined to compare with the C/C genotype)
was 4.368 (95% CI = 2.309 - 8.264, X2: p < 0.0001) in
periodontitis patients (Table 6).
After digestion by AvaII, TNF-a formed the DNA pro-
ducts of 70 and 63 bp for homozygous G alleles, and 63,
49 and 21 bp for homozygous A alleles.81 The detection
frequency of the homozygous G allele of TNF-a was
higher in the subjects with chronic periodontitis (57%)
than the control group (34%) (X2: p < 0.0001, OR: 2.505,
CI = 1.606 - 3.910). Comparing the G/G genotype, peri-
odontitis patients presented higher a frequency of 43%
than 17% in the healthy controls (p < 0.0001). The odds
ratio for carriage of TNF-a allele (A/A and A/G geno-
types combined to compare with the G/G genotype) was
3.716 (95% CI = 1.943 - 7.104) in periodontitis patients
(Table 6).
The homozygous T alleles of IL-4 were represented by a
DNA band with a size of 195 bp, homozygous C alleles
were represented by DNA bands with sizes of 18 and 177
bp [58]. The detection frequency of the homozygous T
alleles of IL-4 was higher in the patient (76%) than control
group (45%). The Chi-Square test result was p < 0.0001,
and the odds ration was 3.837 (95% CI = 2.308 - 6.380)
between the patient and control group. Comparing T/T
genotype, the periodontitis patients presented a higher fre-
quency of 55% in contrast to 18% in periodontally healthy
controls (p < 0.001). The odds ratio for carriage of IL-4
allele (T/T and C/T genotypes combined compared with























*C/C 229(52) 170(20) 4.3681 23.32 C 546(62) 935(55) 1.13597 1.78
T/T 123(28) 85(10) (2.3089-8.2638) <0.0001 T 334(38) 765(45) (0.865-2.1374) 0.1822
C/T 88(20) 595 (70)
IL-1b
*T/T 128(29) 314(37) 0.7132 0.97 T 510(58) 986(58) 0.9974 0
C/C 61(14) 179(21) (0.3624-1.4035) 0.3247 C 370(42) 714(42) (0.6393-1.5559) 1.000
C/T 251(57) 357(42)
IL-6
*G/G 110(25) 408(48) 0.3595 8.57 G 510(58) 1037(61) 0.8781 0.33
C/C/ 25(8) 221(26) 0.177-0.7301 0.0034 C 370(42) 663(39) (0.5626-1.3706) 0.5657
G/C 295(67) 221(26)
TNF-a
*G/G 189(43) 145(17) 3.7156 17.47 G 502(57) 578(34) 2.5054 17.23
A/A 132(30) 408(48) (1.9432-7.1043) 0.0001 A 378(43) 1122(66) (1.6056-3.9095) 0.0001
A/G 119(27) 297(35)
IFN-g
*T/T 251(57) 476(56) 1.0382 0.010.9203 T 580(66) 1105(65) 1.0475 0.04
A/A 106(24) 221(26) (0.5548-1.9427) A 300(34) 595(35) (0.6594-1.664) 0.8415
T/A 83(19) 153(18)
IL-4
*C/C 9(2) 230(27) 16.0032 13.2 C 211(24) 935(55) 3.8369 30.16
T/T 242(55) 153(18) (2.1784-117.5633) 0.0003 T 669(76) 765(45) (2.3075-6.3797) 0.0001
T/C 189(43) 467(55)
IL-10
*A/A 277(63) 782(92) 6.5546 5.211 A 590(67) 1581(93) 6.5731 63.26
G/G 132(30) 51(6) (3.2316-13.2948) 0.0001 G 290(33) 119(7) (3.9186-11.0259) 0.0001
A/G 31(7) 17(2)
IL-1a: T/T+C/T versus C/C; IL-1b: C/C+ C/T versus T/T;
IL-6: C/C+G/C versus G/G; TNF-a: A/A+A/G versus G/G;
IFN-g: A/A+T/A versus T/T; IL-4: T/T +T/C versus C/C;
IL-10: G/G+A/G versus A/A
OR, odds ratio; CI, confidence interval;
Significant difference from the control, *p < 0.05
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the C/C genotype) was 16.003 (95% CI = 2.178 - 117.563)
in periodontitis patients (Table 6).
The homozygous A alleles of IL-10 were represented by
a DNA band with a size of 139 bp, and homozygous G
alleles were represented by DNA bands with sizes of 106
and 33 bp. The detection frequency of the homozygous A
alleles of IL-10 was higher in periodontally healthy con-
trols (93%) than the patient group (67%). The result of the
Chi-square test was p < 0.001, and the odds ratio was
6.573 (95% CI = 3.919 - 11.026) between the disease and
control group. Comparing A/A genotype, the periodontitis
patients presented lower frequency of 63% than 92% in
control (p < 0.001). The odds ratio for carriage of IL-10
allele (G/G and A/G genotypes combined compared with
the A/A genotype) was 6.555 (95% CI: 3.232-13.265) in
periodontitis patients (Table 6).
Other genes investigated in the patients and healthy
subjects (IL-1b, IL-6, IFN-g and IL-10) did not show any
significant difference (p > 0.05), and the lower bound of
confidence interval was below 1.
Overall, significant difference was found in the distribu-
tion of IL-1a, TNF-a, IL-4 and IL-10 between the two
groups (Table 6). For IL-1a, the detection frequency of C
allele was 62% in the patients group and 55% in the con-
trol. The subjects with the C allele are at similar risk for
both groups. The genotype of C/C was significantly higher
in the patient group (52%) than in the controls (20%) (p <
0.001). Individuals with the C/C genotype are at over four
times higher risk for moderate to severe periodontitis than
people with T/T and C/T genotypes (p < 0.001, OR =
4.368 with 95% CI 2.309 - 8.264). The detection frequency
of G allele in TNF-a was 57% in the patients group and
34% in the control group. The patients with the G allele
are at two-fold risk for the disease. The genotype of G/G
was significantly higher in the patient group (43%) than in
the controls (17%) (p < 0.001). Individuals with the G/G
genotype are at nearly four times higher risk for moderate
to severe periodontitis than persons with A/A and A/G
genotypes (p < 0.001, OR = 3.716 with 95% CI 1.943 -
7.104). In IL-4, the detection frequency of C allele was
24% in the patient group and 55% in the healthy control
group. The control subjects with the C allele are at almost
four times less risk for the disease. The genotype of C/C
was significantly lower in the patients (2%) compared to
the healthy controls (27%) (p < 0.001). Individuals with the
C/C genotype are at over sixteen times higher risk for
moderate to severe periodontitis than persons with T/T
and C/T genotypes (p < 0.001, OR = 16.003 with 95% CI =
2.178 - 117.563). The detection frequency of A allele in IL-
10 was 67% in the patient group and 93% in the healthy
control group. The subjects with the A allele are at six-
fold less risk to the disease. The genotype of A/A was sig-
nificantly lower in the patients group (63%) than in the
controls (92%) (p < 0.001). Individuals with the A/A
genotype are over six times at higher risk for moderate to
severe periodontitis than persons with G/G and A/G gen-
otypes (p < 0.001, OR = 6.555 with 95% CI = 3.232 -
13.295).
Discussion
The levels of the proinflammatory cytokines IL-1a, IL-1b,
TNF-a, IFN-g and IL-6 are characteristically increased in
diseased periodontal tissues or gingival crevicular fluid
[60-63]. On the contrary, the initiation and progression of
periodontal inflammation may be due to a lack or inap-
propriate response of the anti-inflammatory cytokines IL-4
and IL-10 in chronic periodontitis [61-63]. The role of
polymorphisms in host responses in the progression of
periodontitis has been well documented in scientific litera-
ture. In most situations, the genetic polymorphisms cause
a change in the protein or its expression altering the
immune response.
The results presented here demonstrate a similar fre-
quency of C and T alleles of IL-1a -889 in CP and con-
trol groups. The frequency of the C allele in CP patients
was 62% which is comparable to other studies in some
populations [64]. The latter demonstrates an important
issue that genetic polymorphism vary among different
ethnic populations, because the carriage rate of C allele
tend to be lower in other Asian populations than the Chi-
nese subjects in our study [65,66]. The frequency of T
allele, in contrast, was higher in the control than CP
group. The IL-1a CC genotype (OR = 4.368; 95% CI =
2.309 to 8.264) was significantly associated with CP. This
is in accordance with other similar studies [67]. In this
study, IL-1b -511 failed to demonstrate an association
with periodontitis, which corresponds to four other stu-
dies to date [68,69]. The carriage rate of rare allele was
the same in the patient and control groups. In all other
previous reports, this rate was similar.
Another proinflammatory cytokine, TNF-a, possesses a
wide range of immunoregulatory functions, including pro-
duction of secondary mediators [70]. Many studies have
investigated the SNPs in the promoter region at positions
-1031, -863, -857, -376, -308, and -238. Among the above
polymorphic sites, position -308 has been most
researched, although most studies failed to demonstrate
an association with periodontitis. However, the present
study managed to showed an association of TNF-a GG
genotype (OR = 3.716; 95% CI = 1.943 - 7.104) with peri-
odontitis. Our studied cases showed a higher frequency of
homozygous (G/G) genotype compared to healthy con-
trols, which could be considered a risk genotype for peri-
odontitis susceptibility.
In the current study, IL-6 did not exhibit an association
with periodontitis, in contrast to studies on Caucasians
and Brazilians [31,37]. The carriage rate of both C and G
alleles was similar in CP and control groups. However,
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the total cases showed a significantly higher frequency of
heterozygous genotype IL-6 -174 (G/C) compared to the
periodontally healthy controls. Thus, IL-6 -174 G/C gen-
otype may be considered a risk genotype for periodontitis
susceptibility.
The IL-4 -590 promoter polymorphism is the most
studied polymorphisms of IL-4. Despite so, case-control
studies have not shown any relationship between the IL-
4 gene polymorphism and susceptibility to chronic peri-
odontitis [71,72]. In contrast, our results demonstrated
an association of IL-4 C/C genotype (OR = 16.003; 95%
CI = 2.178 - 117.563) with a lower frequency in period-
ontitis patients. The T/T genotype, however, was more
prevalent in our patients with periodontitis (55%), sug-
gesting that this may be a risk genotype for periodontitis
susceptibility. A reduction in the frequency of the C/C
genotype in patients confers a protective influence
against the development of the disease.
The IL-10 -1082 polymorphism was evident in our
results, displaying a lower frequency of the A/A geno-
type in periodontitis patients than the healthy controls
(63% versus 92%) [32-34]. A higher frequency of IL-10
-1082 G/G genotype was found in periodontitis patients
(30%), compared to the periodontally healthy controls.
(6%). The results of the clinical trial were in accordance
with previous reports: the proportion of subjects exhibit-
ing the G/G genotype was significantly higher in sub-
jects with severe periodontitis than in periodontally
healthy individuals [73]. The incongruous results can be
explained by the racial difference or association with
other interactive types of cytokines or genetic markers
predisposing for the disease in the studied cases.
Conclusions
The cytokine gene polymorphisms may be used as a
marker for periodontitis susceptibility, clinical behaviour
and severity. This detection offers early diagnosis and
induction of prophylaxis to other family members
against disease progression.
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